The use of antidepressants and the risk of haemorrhagic stroke: A nested case control study

British Journal of Clinical Pharmacology

Volumn 71, Issue 1, 2011, Pages 116-120

  Douglas, Ian ^a   Smeeth, Liam ^a   Irvine, David ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

Author keywords

Antidepressive agents; Haemorrhagic stroke; Pharmacoepidemiology; Serotonin

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; CITALOPRAM; CLOMIPRAMINE; CLOPIDOGREL; DIPYRIDAMOLE; DOSULEPIN; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUPHENAZINE; FLUVOXAMINE; IMIPRAMINE; LOFEPRAMINE; MIANSERIN; MIRTAZAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CASE-CONTROL STUDIES; FEMALE; GREAT BRITAIN; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 78649993136     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03797.x     Document Type: Article

References (12)

1. Dalton SO, Sørensen HT, Johansen C. SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing? CNS Drugs 2006; 20: 143-51.
2. Layton D, Clark DW, Pearce GL, Shakir SA. Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol 2001; 57: 167-76.
3. Tata LJ, Fortun PJ, Hubbard RB, Smeeth L, Hawkey CJ, Smith CJ, Whitaker HJ, Farrington CP, Card TR, West J. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther 2005; 22: 175-81.
4. Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 2004; 164: 2367-70.
5. Smoller JW, Allison M, Cochrane BB, Curd JD, Perlis RH, Robinson JG, Rosal MC, Wenger NK, Wassertheil-Smoller S. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative Study. Arch Intern Med 2009; 169: 2128-39.
6. De Abajo FJ, Jick H, Derby L, Jick S, Schmitz S. Haemorrhagic stroke and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol 2000; 50: 43-7.
7. Bak S, Tsiropoulos I, Kjaersgaard JO, Andersen M, Mellerup E, Hallas J, García Rodríguez LA, Christensen K, Gaist D. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke 2002; 33: 1465-73.
8. Kharofa J, Sekar P, Haverbusch M, Moomaw C, Flaherty M, Kissela B, Broderick J, Woo D. Selective serotonin reuptake inhibitors and risk of haemorrhagic stroke. Stroke 2007; 38: 3049-51.
9. Lawson DH, Sherman V, Hollowell J. The general practice research database. Q J Med 1998; 91: 445-52.
10. The GPRD Practice & Patient Populations - July 2010 Release. Available at (last accessed 29 September 2010).
11. Office for National Statistics. Key Health Statistics from General Practice 1998. London: Office for National Statistics, 2000; 149. Series MB6 No. 2.
12. Andersohn F, Schade R, Suissa S, Garbe E. Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study. Stroke 2006; 37: 1725-30.